Clinical Study of AAV1-gamma-sarcoglycan Gene Therapy for Limb Girdle Muscular Dystrophy Type 2C
Condition(s):Limb Girdle Muscular Dystrophy Type 2C; Gamma-sarcoglycanopathyLast Updated:April 29, 2011Completed
Hide Studies Not Open or Pending
Condition(s):Limb Girdle Muscular Dystrophy Type 2C; Gamma-sarcoglycanopathyLast Updated:April 29, 2011Completed
Condition(s):Limb-girdle Muscular DystrophyLast Updated:March 28, 2024Recruiting
Condition(s):LGMD2CLast Updated:March 7, 2024Not yet recruiting
Condition(s):Gamma-sarcoglycanopathyLast Updated:March 7, 2024Not yet recruiting
Condition(s):Duchenne Muscular Dystrophy; Becker Muscular Dystrophy; Limb Girdle Muscular DystrophyLast Updated:June 15, 2018Completed
Condition(s):LGMD1B; LGMD1C; LGMD1D; LGMD1E; LGMD1F; LGMD1G; LGMD1H; LGMD2A; LGMD2B; LGMD2C; LGMD2D; LGMD2E; LGMD2F; LGMD2G; LGMD2I; LGMD2J; LGMD2K; LGMD2L; LGMD2M; LGMD2N; LGMD2O; LGMD2P; LGMD2Q; LGMD2S; LGMD2T; LGMD2U; LGMD2W; LGMD2X; LGMD2YLast Updated:February 8, 2024Active, not recruiting
Condition(s):Limb Girdle Muscular Dystrophy; Muscular DystrophiesLast Updated:September 13, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.